DAY 1 | Auditorium | DAY 1 |
DAY 1 | Auditorium | DAY 1 |
5:00 | Registration and Refreshments | 5:00: |
5:05: | 5:05: | |
5:10: | 5:10: | |
5:15: | 5:15: | |
5:20: | 5:20: | |
5:25: | 5:25: | |
5:30: | Welcome and Introductions Chairs: Saleha Patel, AstraZeneca Nick Clare, Synthego |
5:30: |
5:35: | 5:35: | |
5:40: | Small molecule-driven targeted RNA degradation for analysis of RNA modifications 17:40 (20 mins) Sigitas Mikutis, University of Cambridge |
5:40: |
5:45: | 5:45: | |
5:50: | 5:50: | |
5:55: | 5:55: | |
6:00 | Intellectual property protection for RNA editing technologies Strategies, claims and pitfalls 18:00 (20 mins) Martin Fabry, IP2 Management Ltd. |
6:00: |
6:05: | 6:05: | |
6:10: | 6:10: | |
6:15: | 6:15: | |
6:20: | Targeting the RNA m6A writer METTL3 for the treatment of cancer 18:20 (20 mins) Oliver Rausch, Storm Therapeutics Ltd |
6:20: |
6:25: | 6:25: | |
6:30: | 6:30: | |
6:35: | 6:35: | |
6:40: | 6:40: | |
6:45: | 6:45: | |
6:50: | 6:50: | |
6:55: | 6:55: | |
7:00 | Networking and Refreshments | 7:00: |
7:05: | 7:05: | |
7:10: | 7:10: | |
7:15: | 7:15: | |
7:20: | 7:20: | |
7:25: | 7:25: | |
7:30: | 7:30: | |
7:35: | 7:35: | |
7:40: | 7:40: | |
7:45: | 7:45: | |
7:50: | 7:50: | |
7:55: | 7:55: | |
8:00 | 8:00: | |
8:05: | 8:05: | |
8:10: | 8:10: | |
8:15: | 8:15: | |
8:20: | 8:20: | |
8:25: | 8:25: | |
8:30: | 8:30: | |
8:35: | 8:35: | |
8:40: | 8:40: | |
8:45: | 8:45: | |
8:50: | 8:50: | |
8:55: | 8:55: | |
9:00 | 9:00: |